Research

INTERASPIRE

Among IAS’ goals is collaboration with other societies and stakeholders to foster research and education on cardio-cerebro-metabolic and thrombosis risk factors. To this end, IAS engaged as a global scientific partner of INTERASPIRE. 

INTERAPSIRE is an international study of 4,548 coronary patients across 14 countries and all six WHO regions. It aims to:

• Describe prevalence of cardiometabolic and renal risk factors
• Describe current risk factor management to defined targets by drug therapies
• Provide an objective assessment of clinical implementation of international and national cardiovascular guidelines
• Investigate the reasons for variation in preventive cardiology practice between regions and countries
• Promote the principles of best preventive cardiology practice through continental and national societies of cardiology and heart foundations.

This project’s other partners include the World Heart Federation, European Society of Cardiology, Inter-American Society of Cardiology, Pan-African Society of Cardiology, and the Asian Pacific Society of Cardiology.

The patient interview and examination data were locked for 14 countries at the end of April 2023. 

INTERASPIRE was accepted for the Late-Breaking Science program at the ESC Congress Amsterdam. Professor Bill McEvoy presented the principal results on Saturday, August 26, 2023 on behalf of all the partner scientific societies. New publications are forthcoming. 

Looking ahead, IAS’ global experts will analyse, present and publish the results on lipids and new international data on Lp(a). This is a great opportunity for the society to contribute to knowledge regarding the regional impact of cardiovascular disease, diabetes, and chronic kidney disease. This information should enhance the implementation of evidence-based preventive measures in diverse communities. 

Collaboration on INTERASPIRE provides a wonderful opportunity for IAS to contribute to the global effort to conquer cardiovascular disease. IAS would like to recognize Amarin Pharma, Inc. for financial support that allowed IAS to become a global partner in this project.

“INTERASPIRE: an International Survey of Coronary Patients; Their Cardiometabolic, Renal and Biomarker Status; and the Quality of Preventive Care Delivered in All WHO Regions” Download PDF